Publication: A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study
| dc.contributor.author | Risslegger, B. (56454345400) | |
| dc.contributor.author | Zoran, T. (59827710800) | |
| dc.contributor.author | Lackner, M. (36676416300) | |
| dc.contributor.author | Aigner, M. (37086880800) | |
| dc.contributor.author | Sánchez-Reus, F. (6507567904) | |
| dc.contributor.author | Rezusta, A. (6601958984) | |
| dc.contributor.author | Chowdhary, A. (7003577085) | |
| dc.contributor.author | Taj-Aldeen, S.J. (6602237737) | |
| dc.contributor.author | Arendrup, M.C. (6701672296) | |
| dc.contributor.author | Oliveri, S. (57193899345) | |
| dc.contributor.author | Kontoyiannis, D.P. (35377023000) | |
| dc.contributor.author | Alastruey-Izquierdo, A. (15834261700) | |
| dc.contributor.author | Lagrou, K. (19134962000) | |
| dc.contributor.author | Lo Cascio, G. (57204236146) | |
| dc.contributor.author | Meis, J.F. (55941779900) | |
| dc.contributor.author | Buzina, W. (56120799500) | |
| dc.contributor.author | Farina, C. (7102038590) | |
| dc.contributor.author | Drogari-Apiranthitou, M. (36083980500) | |
| dc.contributor.author | Grancini, A. (6505794171) | |
| dc.contributor.author | Tortorano, A.M. (57225669881) | |
| dc.date.accessioned | 2025-06-12T16:58:50Z | |
| dc.date.available | 2025-06-12T16:58:50Z | |
| dc.date.issued | 2017 | |
| dc.description.abstract | Objectives A prospective international multicentre surveillance study was conducted to investigate the prevalence and amphotericin B susceptibility of Aspergillus terreus species complex infections. Methods A total of 370 cases from 21 countries were evaluated. Results The overall prevalence of A. terreus species complex among the investigated patients with mould-positive cultures was 5.2% (370/7116). Amphotericin B MICs ranged from 0.125 to 32 mg/L, (median 8 mg/L). Conclusions Aspergillus terreus species complex infections cause a wide spectrum of aspergillosis and the majority of cryptic species display high amphotericin B MICs. © 2017 | |
| dc.identifier.uri | https://doi.org/10.1016/j.cmi.2017.04.012 | |
| dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021237872&doi=10.1016%2fj.cmi.2017.04.012&partnerID=40&md5=5130267ebcc6f2a3fe8f9789a05ecdc8 | |
| dc.identifier.uri | https://remedy.med.bg.ac.rs/handle/123456789/6761 | |
| dc.subject | Amphotericin B | |
| dc.subject | Aspergillosis | |
| dc.subject | Aspergillus terreus | |
| dc.subject | Crytic species | |
| dc.subject | In vitrosusceptibility | |
| dc.title | A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study | |
| dspace.entity.type | Publication | |
